What is the synthetic route and characteristics of Fezonatant?

Fezolinetant: It is a non-hormonal oral drug that has attracted much attention in recent years in the treatment of menopausal-related vasomotor symptoms. It mainly targets the neurokinin 3 receptor (NK3R). At the level of chemical synthesis, the structure of filazonatant is complex and delicate, and it has good oral bioavailability and central nervous system penetration. Its synthesis route has been disclosed in many overseas countries.

Fizolinant usually starts from an aromatic aminopyridine structure and achieves the preparation of the target compound through a series of precisely controlled reaction steps, including halogenation reaction, amination, selective introduction of aromatic ring functional groups, and later fluorine substitution modification. The key steps include coupling the fluorine-containing aromatic hydrocarbon skeleton with the amine side chain through a nucleophilic substitution reaction to form a stable pharmacodynamic core. The entire process reflects the precise grasp of the structure-activity relationship (SAR). The synthetic route is not only efficient, but also highly repeatable and controllable in industrial production.

The synthetic route of nonazonatant also shows certain advantages in green chemistry. For example, non-toxic solvents are used in some steps and the use of heavy metal catalysts can be avoided, which reduces the cost and environmental burden of the subsequent quality control and purification process of the drug. In addition, the molecule has high stability and strong tolerance to heat, humidity and light-sensitive conditions, which facilitates storage and global transportation.

Since it was originally designed to target central nervous system diseases, multi-dimensional pharmacokinetic parameters such as molecular weight, polarity distribution, and charge state were fully considered during the intermediate screening and structure optimization stages. Overall, the synthetic route of fizonatant embodies the all-round consideration of targeting, safety and industrial feasibility in modern drug design, and is a representative case in the development paradigm of small molecule drugs.

Reference materials:https://www.veozah.com/